rxstat › Shortages › Cefprozil
Cefprozil shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Cefprozil products are in shortage in Canada (1 of 16 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Sep 25, 2018
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-CEFPROZIL
500MG · TABLET · APOTEX INC
DIN 02293005 · since Sep 25, 2018, no end estimate · Disruption of the manufacture of the drug.
ResolvedAURO-CEFPROZIL
500MG · TABLET
TABLET · AURO PHARMA INC
DIN 02347253 · ended Mar 6, 2025 · Demand increase for the drug.
ResolvedAURO-CEFPROZIL
250MG · POWDER FOR SUSPENSION · AURO PHARMA INC
DIN 02347288 · ended Dec 16, 2024 · Demand increase for the drug.
ResolvedAURO-CEFPROZIL
250MG · POWDER FOR SUSPENSION · AURO PHARMA INC
DIN 02347288 · ended Dec 16, 2024 · Demand increase for the drug.
ResolvedAURO-CEFPROZIL
125MG · POWDER FOR SUSPENSION · AURO PHARMA INC
DIN 02347261 · ended Dec 16, 2024 · Demand increase for the drug.
ResolvedAURO-CEFPROZIL
125MG · POWDER FOR SUSPENSION · AURO PHARMA INC
DIN 02347261 · ended Dec 16, 2024 · Demand increase for the drug.
ResolvedAURO-CEFPROZIL
500MG · TABLET
TABLET · AURO PHARMA INC
DIN 02347253 · ended May 30, 2024 · Demand increase for the drug.
ResolvedTARO-CEFPROZIL
125MG · POWDER FOR SUSPENSION · SUN PHARMA CANADA INC
DIN 02329204 · ended Aug 21, 2023 · Disruption of the manufacture of the drug.
ResolvedTARO-CEFPROZIL
125MG · POWDER FOR SUSPENSION · SUN PHARMA CANADA INC
DIN 02329204 · ended Aug 21, 2023 · Disruption of the manufacture of the drug.
ResolvedTARO-CEFPROZIL
250MG · POWDER FOR SUSPENSION · SUN PHARMA CANADA INC
DIN 02293579 · ended Oct 16, 2023 · Disruption of the manufacture of the drug.
ResolvedTARO-CEFPROZIL
250MG · POWDER FOR SUSPENSION · SUN PHARMA CANADA INC
DIN 02293579 · ended Oct 16, 2023 · Disruption of the manufacture of the drug.
ResolvedTARO-CEFPROZIL
125MG · POWDER FOR SUSPENSION · SUN PHARMA CANADA INC
DIN 02329204 · ended Dec 23, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 36 reports. All reports are on file with Health Canada.
What's happening
Cefprozil is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Cefprozil is classified under “OTHER BETA-LACTAM ANTIBACTERIALS” (ATC J01DC).
Recent changes
Common questions
When will Cefprozil be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Cefprozil in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All other beta-lactam antibacterials shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.